Exxon Mobil To $120? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several companies, including Exxon Mobil, Hut 8, McKesson, BioNTech, Banc of California, Maplebear, Comerica, Celsius Holdings, Braze, and Light & Wonder. These changes reflect varying outlooks on the stocks, with some being upgraded and others downgraded.
September 24, 2024 | 12:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wedbush raised Banc of California's price target to $18 and upgraded the stock to Outperform. Shares fell 1.4% to $14.84.
Despite the share price drop, the upgrade and increased price target suggest a positive outlook, potentially leading to a future price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Morgan Stanley raised BioNTech's price target to $145 and upgraded the stock to Overweight. Shares gained 0.7% to $113.05.
The upgrade and increased price target indicate a positive outlook, likely boosting investor confidence and share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Wedbush raised Comerica's price target to $75 and upgraded the stock to Outperform. Shares fell 2.1% to $60.20.
Despite the share price drop, the upgrade and increased price target suggest a positive outlook, potentially leading to a future price increase.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Needham increased Hut 8's price target to $16.5 and maintained a Buy rating. Shares gained 3.6% to $11.57.
The increased price target and maintained Buy rating indicate a positive outlook, likely boosting investor confidence and share price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
Susquehanna cut Light & Wonder's price target to $90, maintaining a Neutral rating. Shares gained 0.1% to $112.68.
The slight price target reduction and neutral rating suggest a stable outlook, with minimal short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 100
NEUTRAL IMPACT
Redburn Atlantic raised Exxon's price target to $120 but downgraded the stock from Buy to Neutral. Exxon shares rose 1.8% to $117.36.
The price target increase suggests a positive outlook, but the downgrade to Neutral tempers expectations, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Oppenheimer cut Braze's price target to $51, maintaining an Outperform rating. Shares fell 4.9% to $34.62.
The reduced price target and significant share price drop suggest a negative short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Morgan Stanley cut Maplebear's price target to $41, maintaining an Equal-Weight rating. Shares fell 4.6% to $40.22.
The reduced price target and significant share price drop suggest a negative short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Piper Sandler cut Celsius Holdings' price target to $47, maintaining an Overweight rating. Shares fell 1.1% to $32.80.
The reduced price target and share price drop suggest a negative short-term outlook for the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Baird cut McKesson's price target to $531 and downgraded the stock to Neutral. Shares fell 0.6% to $505.00.
The downgrade and reduced price target suggest a less favorable outlook, likely leading to a negative short-term impact on the stock.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100